study	individual	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	value	mean	mean_pm	sd	se	unit	comments
Goldberg1995a	NA	all	12.0	placebo	auc_end	aldosterone	plasma	RIA	placebo_abz_change_ald	12.0	hr	NA	6.5	NA	NA	NA	ng/dl*hr	area about zero for change from run-in
Goldberg1995a	NA	all	12.0	placebo	auc_end	aldosterone	plasma	RIA	placebo_abz_change_ald	324.0	hr	NA	15.0	NA	NA	NA	ng/dl*hr	area about zero for change from run-in
Goldberg1995a	NA	all	12.0	placebo	auc_end	aldosterone	plasma	RIA	placebo_abz_change_ald	996.0	hr	NA	19.9	NA	NA	NA	ng/dl*hr	area about zero for change from run-in
Goldberg1995a	NA	all	11.0	LOS25	auc_end	norepinephrine	plasma	HPLC/ECD	LOS25_abz_change_nor	12.0	hr	NA	360.5	NA	NA	NA	ng/ml*hr	area about zero for change from run-in
Goldberg1995a	NA	all	11.0	LOS25	auc_end	norepinephrine	plasma	HPLC/ECD	LOS25_abz_change_nor	324.0	hr	NA	757.6	NA	NA	NA	ng/ml*hr	area about zero for change from run-in
Goldberg1995a	NA	all	11.0	LOS25	auc_end	norepinephrine	plasma	HPLC/ECD	LOS25_abz_change_nor	996.0	hr	NA	81.5	NA	NA	NA	ng/ml*hr	area about zero for change from run-in
Goldberg1995a	NA	all	13.0	LOS100	auc_end	norepinephrine	plasma	HPLC/ECD	LOS100_abz_change_nor	12.0	hr	NA	198.7	NA	NA	NA	ng/ml*hr	area about zero for change from run-in
Goldberg1995a	NA	all	13.0	LOS100	auc_end	norepinephrine	plasma	HPLC/ECD	LOS100_abz_change_nor	324.0	hr	NA	617.3	NA	NA	NA	ng/ml*hr	area about zero for change from run-in
